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Abstract
[Aim] The definition of good adherence to continuous positive airway pressure (CPAP) 
therapy for obstructive sleep apnea syndrome (OSA) is a utilization rate of ≥70% and a 
mean usage time on usage days of ≥4 hours, and users who deviate from this definition 
are regarded as having poor adherence. Personalized guidance is required to improve the 
adherence of users with poor adherence. Hence, a more detailed classification is needed 
rather than simply classifying users as having poor and good adherence. Thus, this study 
aimed to clarify the significance of classification of adherence into four groups based on 
the two indices of utilization rate (%) and mean usage time (hours).
[Method] This study examined CPAP users at the CPAP specialist outpatient department 
from October to November 2016. In total, 535 patients were included, and information 
on CPAP adherence, physical data at initial consultation, and data on motivation for 
consultation were collected. The survey period was set as 2 months. The CPAP users 
were divided into four groups, and a 4-group comparison was conducted on factors that 
affect adherence, using the χ ² test, the Kruskal-Wallis test, and the pairwise method. 
The utilization rate was set as the vertical axis and the mean usage time on usage days 
was set as the horizontal axis to create a scatter plot. The four segments were created by 
intersecting the axes with the values of “70%” and “4 hours”, with the top right set as 
the good adherence group “≥70%/≥4 hours”; moving counterclockwise, the next segments 
were set as the insufficient adherence time group “≥70%/<4 hours,” poor adherence group 
“≤70%/<4 hours,” and insufficient adherence days group “<70%, ≥4 hours.” 
[Results] The good adherence group (n=393) accounted for 70% of users; the remaining 
30%, conventionally classified together as users with poor adherence, were distributed into 
insufficient adherence time group (n=31), poor adherence group (n=49), and insufficient 
adherence days group (n=62). No significant differences in sex or residual AHI were 
observed, but significant difference was observed in age, usage history, and BMI between 
the good adherence group and poor adherence group. The percentage of patients with 
hypertension was significantly different between the good adherence group and insufficient 
adherence days group. There was a significant difference in the percentage of patients 
who sought consultation due to subjective symptoms between the insufficient adherence 
days group and insufficient adherence time group. The percentage of patients who sought 
consultation due to a recommendation by a company medical checkup showed a significant 
difference between the good adherence group and insufficient adherence days group.
[Conclusion] These results suggest that adherence can be divided into four groups based 
on utilization rate and mean usage time on usage days, and that these classifications may 
be helpful for constructing a guidance management system that emphasizes personalized 
guidance systems.
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　Introduction
　Continuous positive airway pressure （CPAP） therapy 
was first reported in 1981 as an alternative therapy to 
tracheostomy for obstructive sleep apnea syndrome 
（OSA） 1）. Research outcomes have been accumulated 
as evidence during the intervening period of almost 40 
years, and CPAP is currently widely used as first-line 
therapy for OSA in Western countries and in Japan2-5）.
　In 1998, public insurance was applied to CPAP in 
Japan; monthly consultations are generally mandated 
for CPAP users, and medical practitioners are obligated 
to provide guidance and management6）. Two major 
changes have been observed in the intervening 20 years 
since that time.
　The first is the improvement in the CPAP machine 
and interface. The first CPAP machines were ventilators 
that forced breathing, and required the user to wear 
a helmet-like mask. However, now the machines 
are quieter, smaller, lighter, and more automated, 
and have improved into advanced precision medical 
equipment7- 8）. Comfort, sealing, and design were 
also pursued for the interface9）. These changes have 
resulted in a comfortable breathing experience. The 
machines are now also equipped with memory functions 
that not only record the usage days and usage hours, 
but also sense and record the user’s apnea hypopnea 
index （AHI） and mask leaks, which enables detailed 
evaluation of the adherence of each individual user10）. 
Furthermore, development of self-powered CPAP 
machines that can be used during disasters, coupled 
with development of information and communication 
technology, have now enabled machines that support 
remote monitoring, with potential further advances in 
the future11）.
　One other change is the discovery that CPAP is 
effective for a variety of people. The first patients 
were only those with subjective symptoms of OSA. 
However, as research progressed, it was found that 
unlike Westerners, Japanese people were prone to the 
sleep apnea syndrome （SAS）, even when they were 
not obese. This was due to the maxillofacial shape 
unique to Asians12）. Moreover, SAS was revealed to not 
only affect the symptoms of daytime sleeping, but also 
lifestyle diseases, such as hypertension13）, cardiovascular 
disease14-15） and diabetes16）. Therefore, a joint research 
team comprising the Japanese Circulation Society and 
7  other societies created guidelines for the diagnosis 
and treatment of SAS17）. As a result, the participants 
and related diseases were diversified to include elderly 
patients, women, non-obese patients, and patients with 
a history of cardiovascular disease.
　The concept of adherence in CPAP research also 
changed with the aforementioned changes. In the 
beginning, when CPAP was first listed under public 
insurance, deciding whether to continue or discontinue 
CPAP was an important issue, and emphasis was 
placed on not discontinuing the therapy. Therefore, 
continuation factors and discontinuation predictors were 
investigated by comparing the continuation group to the 
discontinuation group18-20）. Discontinuation factors were 
not identified as a result of this research, but it was 
found that a variety of factors exerted a complex effect 
that resulted in discontinuation, and measures were 
adopted to prevent discontinuation, including machine 
development and innovations for early education21-22）. 
Additionally, with the recent improvements in CPAP 
machines, attention is now more focused on the 
quality of adherence of users who continue to use the 
machines, rather than on whether or not users stopped 
using the CPAP machines.
　CPAP adherence is defined as “compliance to a 
utilization rate of ≥70% and a mean usage time on 
usage days of ≥4 hours” 23-24）. The quality of adherence 
is evaluated as “good” for people who use the machine 
in accordance with the definition and as “poor” for 
people who do not use the machine in accordance 
with the definition. It is necessary to provide guidance 
and management to people with “poor” adherence to 
change their behavior to “good” adherence, to achieve 
the goals of CPAP therapy.
　The current guidance and management have been 
made into a flowchart for each problem item, with each 
problematic event dealt with according to the problem, 
such as mask fitting and mask changes implemented for 
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mask problems, a combination of otorhinolaryngological 
therapy and humidifiers used to address nasal/oral 
symptoms, and adjusting the CPAP pressure if patient 
does not actually experience a therapeutic effect25-26）. 
However, it is difficult to say that these measures 
address the diversity of the lifestyle background, 
directivity, and related diseases of CPAP users.
　This can be explained by the results of a previous 
qualitative study27）that clarified the behavior of CPAP 
usage in non-obese patients. The study showed that 
adherence in non-obese patients was higher than in 
obese patients and, interestingly, they performed CPAP 
with a focus on time and days. Therefore, to increase 
the adherence to CPAP, which should be used every 
day, it is necessary to consider the factors of time and 
days.
　This means that the same intervention method for a 
certain problematic event is not necessarily optimal for 
improving CPAP adherence. In other words, it is vital 
to convert to guidance and management that intervenes 
with problems depending on the characteristics of 
the CPAP users and adherence quality, rather than 
intervention focused on the problematic event itself.
　Therefore, this study aimed to evaluate the 
four classifications of adherence quality, rather 
than the current two, and to discover whether 
lifestyle background, directivity, and related disease 




　The study examined CPAP users seen at the 
CPAP specialist outpatient department from October 
to November 2016. For patients who visited the 
department several times during the survey period, 
the initial data during the period were adopted, and 
535 patients were included in the study as patients 
for whom information on CPAP adherence, physical 
data at initial consultation, and data on motivation 
for consultation could be collected. The medical 
institution for the surveyed patients was a hospital 
that had focused on the correlation between SAS and 
lifestyle diseases from an early stage in Japan and 
had a specialist CPAP outpatient department. Fall was 
selected as the survey period, as fall has relatively little 
impact on the condition.
　２.  Method of classifying adherence quality into 
four groups
　The method of classifying adherence quality into 
four groups was based on the four classification criteria 
proposed by Sakurai28）. In 2003, Sakurai proposed 
a method of setting the “rate of effective use （%）” 
as the vertical axis, and the “total rate of use （%）” 
as the horizontal axis and classifying adherence into 
four groups based on where each value intersected 
at 70%, in an attempt to classify the characteristics 
of adherence. It is thought that this method based 
on four classifications did not become widespread 
due to the cumbersome calculations caused by the 
limited functions of the CPAP machines at the time. 
However, usage time can now be easily calculated 
with recent CPAP machines and it is also possible to 
find the average usage time only on the day of use. 
This is thought to have led to the expansion of the 
ability of self-management by removing the complexity 
of calculations. Therefore, in this study we used the 
method of classification of adherence into four groups 
using the two axes of “utilization rate” and “mean usage 
time”, which can now be easily calculated by the CPAP 
machines.
　The specific method used to classify adherence into 
four groups was based on the definition of adherence of 
a “utilization rate of ≥70% and a mean usage time on 
usage days of ≥4 hours”. The “utilization rate” was set 
as the vertical axis, and the “mean usage time on usage 
days” was set as the horizontal axis, and these are the 
adherence indices. Four segments were created by 
intersecting the two axes at the reference values of “70
%” and “4  hours”. The top right of the four segments 
was named Group I, and moving counterclockwise, 
the next segments were named Groups II, III, and 
IV, reflecting the following qualities of adherence for 
the four groups. The criteria and names are as set out 
below.
　Group I: Utilization rate ≥70%, mean usage time ≥4 
hours: good adherence group
　Group II: Utilization rate≥70%, mean usage time <4 
hours: insufficient adherence time group
　Group III: Utilization rate<70%, mean usage time <4 
hours: poor adherence group
　Group IV: Utilization rate<70%, mean usage time ≥4 
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hours: insufficient adherence days group
　３.  Factors related to adherence and data collection 
methods
　1） Data related to adherence
　Data used as indicators of adherence were based 
on functions that calculate the CPAP internal memory 
data, calculated by the CPAP machines. We collected 
the usage time on usage days collected with the CPAP 
internal memory, averaged by the number of days the 
machine was used. Data since the previous consultation 
were recorded in the internal memory brought in by 
the CPAP users, and the data that form the CPAP sleep 
index were downloaded to electronic medical records 
from the CPAP internal memory with a dedicated 
analysis software.
　The “utilization rate” was used to calculate the ratio 
of usage days from the sum of the number of usage 
days and the number of non-usage days recorded in 
the CPAP internal memory. The “mean usage time on 
usage days” was calculated by averaging the usage time 
on the days that CPAP was used.
　2） Data showing the characteristics
　Data on characteristics were extracted from 
the results of previous studies18-20）, and data were 
collected from the medical records into the following 
characteristics.
　（1）  Medical data: Consultation interval for CPAP 
outpatient, Number of CPAP usage days and non-
usage days, CPAP usage time per day, residual 
AHI, and CPAP usage history （months of usage）
　（2）  Physical data: sex, age, and body mass index 
（BMI） indicating the degree of obesity at 
introduction of CPAP
　（3） Medical history:
　（4）  Motivation for consultation: Based on the data 
collected on the first visit, the following six 
categories were made.
　・ Sought consultation due to subjective symptoms
　・ Recommended by family
　・ Recommended by a cardiologist
　・  Recommended by medical personnel other than 
cardiologists
　・ Recommended by an acquaintance
　・ Recommended by company medical checkup
　４. Analysis method
　A scatter plot was used to confirm whether CPAP 
users could be classified into four groups based on 
CPAP adherence indices, and a 4-group comparison 
was conducted for adherence, medical, and physical 
data, medical history, and motivation for consultation. 
IBM SPSS Statistics 24 （IBM Crop., Armonk, NY） was 
used for all statistical analyses. Data were displayed as 
mean ± standard deviation; because it is not normally 
distributed, the Kruskal-Wallis test was used for analysis 
of continuous variables, and pairwise comparison 
was conducted as multiple comparisons for instances 
where significant differences were observed. Pearson’s
χ 2 test was used for analysis of categorical variables, 
and Fisher’s exact test was used when the expected 
frequency was less than 5  cells and more than 20% of 
all cells. Level of significance was set at p<0.05.
　５. Ethical considerations
　This research was a retrospective study, with clinical 
sleep information and other information obtained from 
medical records. Therefore, the director of the hospital 
ensured that the opt-out study was made public and the 
opportunity for refusal was granted, and considerations 
were made to ensure individuals could not be identified. 
This study was approved by the medical ethics review 
board of University A （Approval Number: 710- 1）， 
and was implemented after obtaining approval from 
the ethics review board of the medical institution that 
cooperated with the research.
　Results
　１. Outline of participants
　Among the 535 participants, 413 （77.2%） and 122 
（22.8%） were men and women, respectively, with 
a mean age of 63.3±13.4 years （mean ± standard 
deviation）; the mean number of years of CPAP use 
was 4.0±3.2 years （Table 1）.
　The CPAP outpatient consultation interval was 
one, two, and three months for 207, 190, and 138 
participants, respectively. There was no significant 
differences in the consultation interval between the 
groups （Table 2）.
　２. CPAP users scatter plot based on “utilization 
rate” and “mean usage time on usage days”
　The “utilization rate” was set as the vertical axis, 
and the “mean usage time on usage days” was set as 
the horizontal axis. The four segments were created 
by intersecting the axes with the values of “70%” and 
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“ 4  hours”, and the degree of variation among the 
participants is shown in a scatter plot. The breakdown 
of the groups is as follows: 73.5% （n=393） of the 
participants were in the good adherence group （top 
right）; 5.8% （n=31） were in the insufficient adherence 
time group （top left）; 9.1% （n=49） were in the poor 
adherence group （bottom left）, and 11.6% （n=62） 
were in the insufficient adherence days group （bottom 
right） （Figure 1）.
　３.  Comparison of related factors among the four 
groups.
　1） Medical data: residual AHI, CPAP usage history 
（months of usage）
　The mean value of residual AHI, which indicates the 
incidence of apnea-hypopnea while using CPAP, was at 
most 5  times per hour, which is the medical outcome, 
for all groups. The results of the Kruskal-Wallis test 
revealed no significant differences among the groups 
（p=0.157）.
　A significant difference existed in the CPAP months 
of usage, which represents CPAP history （p=0.001）, 
and the results of multiple comparisons revealed that 
the poor adherence group had significantly less usage 
history than the good adherence group   （Table 4）.
　2） Physical data: Sex, age, and BMI at introduction 
of CPAP
　When a χ2 test for independence was conducted 
to determine the association between sex and each 
group, the result was p=0.785, indicating no significant 
association （Table 3）.
　A significant difference was observed among the four 
groups （p<0.001） in the comparison of the mean ages 
using the Kruskal-Wallis test, and the results of multiple 
comparisons indicated that the good adherence group 
Table 1. Participant characteristics (n =535)
Figure 1  "Scatterplot of adherence of CPAP users"
Breakdown when the top right of the four segments is set as the good adherence group, and moving counterclockwise, the 
next segments are set as the insufficient adherence time group，poor adherence group and insufficient adherence days group
Group Ⅰ：Good adherence group (n=393)
Group Ⅱ：Insufficient adherence time group (n=31)
Group Ⅲ：Poor adherence group (n=49)
Group Ⅳ：Insufficient adherence days group (n=62)
Table 2. The consultation interval for CPAP users (n =535)
Characteristics N (%) Mean ± SD
Sex Male 413 (77.2)
 Female 122 (22.8)
Age (years) 63.3 ± 13.4
BMI before starting CPAP (kg/m2) 26.9 ± 4.9
Number of years using CPAP (years) 4.0 ± 3.2
CPAP utilization rate (%) 83.7 ± 23.1
Mean CPAP usage time/day (hours)  5.6 ± 1.6
Consultation interval 1 month 207 (38.7)
 2 month 190 (35.5)
 3 month 138 (25.8)
 SD standard deviation, BMI body mass index, CPAP continuous positive airway pressure
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1 month 2 month 3 month
n=207 n=190 n=138
Group n n (%) n (%) n (%) p-value
Ⅰ   Good adherence group 393 147 (37.4) 137 (34.9) 109 (27.7)
Ⅱ   Insufficient adherence time group 31 13 (41.9) 13 (41.9) 5 (16.1)
Ⅲ   Poor adherence group 49 23 (46.9) 17 (34.7) 9 (18.4)
Ⅳ   Insufficient adherence days group 62 24 (38.7) 23 (37.1) 15 (24.2)
Kruskal-Wallis test
Table 2. The consultation interval for CPAP users (n=535)
the consultation interval 
0.871
Table 3. Comparison among 4  groups in sex












days group χ²value p-value
Male     n=413   n (%) 299（72.4） 25（6.1） 39（9.4） 50（12.1）
Famale n=122   n (%)  94（77.1.） 6（4.9） 10（8.2） 12（9.8）
χ² test  
0.7851.066
Table 3. Comparison among 4 groups in sex
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was significantly older than the poor adherence and the 
insufficient adherence days groups （p<0001）. Given 
that a significant difference was observed with the 
insufficient adherence time group （p<0.05）, the good 
adherence group was significantly older.
　A significant difference existed in the mean BMI at 
introduction of CPAP （p=0.012）, and the results of 
multiple comparisons indicated that the poor adherence 
group tended to be more obese than the good 
adherence group （Table 4）.
　3） Medical history
　For medical history, Pearson’s χ2 test was performed 
for each of the six diseases. Fisher's exact test was 
performed only for “depression” because it had an 
expected frequency of less than 5  cells and more 
than 20% of all cells. As a result, no significant 
differences were observed among the groups in terms 
of diabetes, cardiovascular disease, stroke, depression, 
or dyslipidemia, with the exception of hypertension 
（p=0.020）. The residual analysis showed that the 
percentage of patients with hypertension was high 
and low in the good adherence group and insufficient 
adherence days group, respectively （Table 5）.
　4） Motivation for consultation
 The Pearson’s χ2 test or Fisher's exact test 
was performed for each of the six categories of 
motivation for consultation, as described above. No 
significant differences existed among the groups 
for recommendation from family, medical staff, or 
acquaintances, but significant differences existed for 
“sought consultation due to subjective symptoms” （p=
0.003） and “company medical checkup” （p=0.001）. The 
residual analysis showed that the percentage of patients 
Table 5. Comparison of medical history between the four 
groups
Table 6.  Comparison of the motivation for consultation between 
the four groups
χ² value p-value
Table 5. Comparison of medical history between the four groups
Group I Group II Group III Group IV
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Dyslipidemia 138 (35.1) 12 (38.7) 15 (30.6) 22 (35.5)
0.1
χ² test ,   †Fisher’s exact test,
Motivation for consultation





Recommended by a cardiologist
Adjusted standardized residual
Recommended by medical personnel
other than a cardiologists
Adjusted standardized residual
Recommended by an acquaintance
Adjusted standardized residual
Recommended by company medical
checkup
Adjusted standardized residual
Table 6. Comparison of the motivation for consultation between the four groups















n=393 n=31 n=49 n=62
n (%) n (%) n (%) n (%)
57 (14.5) 11 (35.5) 7 (14.3) 4 (6.5)
0.003
-0.3 3.3 -0.1 -2
14.008
55 (14.0) 3 (9.7) 8 (16.3) 9 (14.5)
0.87
0 -0.7 0.5 0.1
0.714
174 (44.3) 11 (35.5) 15 (30.6) 29 (48.8)
0.221
1.1 -0.8 -1.8 0.7
4.400
84 (21.4) 5 (16.1) 14 (28.6) 12 (19.4)
0.541
-0.1 -0.7 1.3 -0.4
2.155
12 (3.1) 1 (3.2) 1 (2.0) 0
0.055†
1.1 0.2 -0.3 -1.4
_
0.002†
-2.8 -1.2 1.4 3.6
_
χ² test,    †Fisher’s exact test
11 (2.8) 0 4 (8.2) 8 (12.9)















Group I Group II Group III Group IV
Good adherence group Insufficient adherencetime group Poor adherence group
Insufficient adherence
days group
n=393 n=31 n=49 n=62
Medical data
2.7 ± 2.6 3.2 ± 2.4 3.3 ± 3.0 2.4 ± 1.9
[2.4, 3.0] [2.3, 4.1] [2.4, 4.1] [1.9, 2.8]
[64.4, 66.9] [55.1, 63.9] [50.2, 57.1] [54.8, 61.1]
Months using CPAP (months)
50.7 ± 39.3 40.3 ± 42.7 29.8 ± 27.0 44.3 ± 34.9
[46.8, 54.6] [24.7, 56.0] [22.0, 37.6] [35.5, 53.2]
Table ４ 　CPAP user background
Kruskal-Wallis test, Multiple comparison (Pairwise method) ,  AHI apnea hypopnea index, SD standard deviation,
Cl confidence interval,, CPAP continuous positive airway pressure, BMI body mass index, *p<0.05 **p<0.01
***p<0.001
BMI before starting CPAP (kg/m2)
26.7 ± 4.9 25.9 ± 3.6 29.5 ± 6.1 27.0 ± 4.4
[26.2, 27.2] [24.6, 27.2] [27.7, 31.2] [25.9, 29.2]
Physical data
65.6 ± 13.0 59.5 ± 11.9 53.6 ± 11.9 57.9 ± 12.4
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in the “sought consultation due to subjective symptoms” 
category was high and low in the insufficient adherence 
time group and insufficient adherence days group, 
respectively. Whereas the percentage of patients in the 
“recommended by company medical checkup” category 
was high and low in the insufficient adherence days 
group and good adherence group, respectively （Table 
6）.
　Discussion
　１.  Significance of successfully classifying CPAP 
adherence into four groups
　 Here we discuss the significance of grouping 
adherence into four groups based on this overall 
distribution.
　1） Relationship with the distribution population
　The good adherence group located in the top right 
has a “utilization rate of ≥70% and a mean usage 
time on usage days of ≥ 4 hours”, which is defined 
as adherence, and therefore corresponds to the 
conventional “good adherence group”. Given that this 
group accounts for 73.5% of the whole, the CPAP 
adherence in Japan is consistent with that reported 
in the findings of reports indicating that 70% of users 
are in the good adherence group, whereas 30% are in 
the poor adherence group29）, which demonstrates the 
validity of this study.
　A certain percentage of CPAP users were distributed 
in the “insufficient adherence time group”, “poor 
adherence group”, and “insufficient adherence 
days group”, positioned in the top left, bottom left, 
and bottom right sides, respectively, which are 
conventionally all grouped together as the “poor 
adherence group”. The percentage of patients in each 
group is shown. Although there was no report in which 
the patients were divided into four groups as described 
here, the results reported for the two groups of good 
adherence and poor adherence were consistent with the 
result of this study which is 7 :3. Therefore, the general 
population can be divided into these four groups. 
Moreover, the distribution of patients in these fours 
group may be representative of the general population. 
However, further studies are needed to confirm this.
　2）  Significance of a lack of significant difference in 
residual AHI among the four groups
　Previous studies often compared the values of AHI 
at diagnosis of SAS before introduction of CPAP. 
However, no consensus was reached, as some studies 
revealed that the more severe the AHI value before 
CPAP was introduced, the better was the adherence 
to CPAP19）. In contrast, other studies revealed no 
significant differences in AHI at diagnosis of SAS in the 
continuation and discontinuation groups18）. Recently, 
the number of SAS patients who are non-obese and 
lack subjective symptoms has increased. Therefore, this 
study focused on residual AHI to objectively evaluate 
the effect of CPAP, rather than AHI at diagnosis of SAS 
before CPAP was introduced. Residual AHI represents 
the number of times apnea hypopnea occurs while 
using CPAP; if residual AHI is high, then the doctor 
determines that effective CPAP is not being used, and 
then changes the CPAP setting pressure.
　The results of this study indicated that all groups 
cleared the target of 5  or less times per hour, with 
no significant difference among the groups. This 
means that adherence is not affected by how skillfully 
the doctor correctly sets the CPAP pressure nor by 
achieving the medical outcome. In other words, even 
if the CPAP pressure set by a doctor is optimal, it 
does not always lead to patients consistently using 
CPAP. This suggests that it is not possible to improve 
adherence by simply achieving the medical outcome of 
residual AHI, instead, it is essential to consider certain 
patient characteristics.
　２. Utilization in clinical practice
　Here we discuss how grouping into four groups can 
be used effectively in actual clinical practice.
　1） Focusing on sex and age
　Previous studies reported that CPAP continuation 
rate was slightly lower in women30）, but the prevalence 
of OSA in Japan is reportedly 6- 7  times higher in 
men than in women31）, and the small cohort of female 
participants mean that there are few previous studies 
that compared sex differences for adherence, and 
there is no fixed opinion on this matter. There were no 
significant sex-related differences among the groups in 
this study. With the recent improvements in the mask 
interface, it is presumed that there is now a reduced 
tendency for the masks to leave indentations and the 
design of the mask has also improved, which may have 
led to improved adherence in women.
　There are conflicting reports about age, with some 
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reports indicating that the younger the patient, the 
poorer the adherence due to a lack of a sense of danger 
and sense of urgency regarding complications, thus, 
the older the patient, the better the adherence20）, while 
other reports claim that elderly patients have poor 
adherence due to a lack of subjective symptoms32）. 
However, the results of this study indicate that the 
good adherence group was significantly older than 
the other groups, hence the older the patient the 
better the adherence, and the younger the patient the 
poorer the adherence. This result is thought to be 
because older patients are more likely to adhere to 
healthy behaviors based on experience than younger 
patients, as described in previous studies20）. The recent 
improvements in CPAP machines, which make it easier 
for elderly patients to operate the machine, have also 
promoted greater CPAP adherence among the elderly. 
Additionally, CPAP masks such as a nasal mask or 
nasal pillow mask are being developed that differ from 
the conventional full-face mask and have a design that 
minimizes the skin contact area9）.
　Therefore, improvements in devices such as CPAP 
devices and masks target the needs of all generations 
and sex. In the future it will be necessary to examine 
intervention methods that closely match the needs of 
CPAP users for guidance and management.
　2）  Focusing on CPAP usage history and BMI at 
introduction of CPAP
　The good adherence group had significantly longer 
CPAP usage than the poor adherence group. This 
is consistent with the finding that generally most 
people who stop using CPAP do so within the first 
year33）. This is the reason why early education at 
introduction of CPAP is considered to be important, 
and the reason that facilities provide guidance and 
management intervention selectively for patients who 
have poor adherence immediately after introduction 
of CPAP. Here, we would like to draw attention to the 
fact that in this study no significant difference existed 
between the insufficient adherence time and insufficient 
adherence days groups. In other words, this means that 
a certain number of CPAP users continue using CPAP 
for any number of years without adequate adherence, 
namely insufficient time and insufficient number of 
days. In a busy clinical practice, the CPAP usage history 
of the insufficient adherence time and insufficient 
adherence days groups is shorter, and the guidance and 
management tend to be a lower priority than the poor 
adherence group, who are more likely to discontinue 
use. However, using ineffective CPAP is futile, so it 
is essential to proactively and effectively intervene in 
the insufficient adherence time group and insufficient 
adherence days group.
　A significant difference was observed in BMI at 
introduction of CPAP between the good adherence 
group and the poor adherence group. Many existing 
studies report that BMI does not affect adherence34）. 
However, these are research reports from a time when 
many of the patients were obese with a mean BMI 
of around 30 kg/m2. This does not suit the current 
scenario where CPAP users are diverse, including 
non-obese patients. The results of the present study 
indicated that the more obese the participant the poorer 
the adherence, and the less obese the participant the 
better the adherence. As medical staff, we present the 
goal of “if you lose weight you can stop using CPAP” to 
obese patients, but we do not present the goal of losing 
weight to non-obese patients. Despite not presenting 
a goal, non-obese patients have better adherence than 
obese patients. This means that to impart a sense of 
crisis in obese people in the poor adherence group, it 
may not be correct to simply imply the goal of “if you 
lose weight you can stop using CPAP”.
　Based on the above findings, dividing the participants 
into four groups makes it possible to subcategorize the 
priority of guidance and management and revise the 
wording used for these patients.
　3） Use of medical history
　Previous studies, such as the one conducted by 
Noguchi reported that patients with a history of 
cardiovascular diseases tended to frequently use 
CPAP35）, so it was assumed that patients with a history 
of cardiovascular disease had good adherence, but 
in this study, no significant difference was observed 
for cardiovascular diseases. Only hypertension was 
significantly different between the groups, and the 
good adherence group had more participants with a 
history of hypertension than the insufficient adherence 
days group. This finding suggests that awareness of 
hypertension may slightly increase adherence. However, 
the participants reported their medical history through 
a multiple-choice questionnaire, and it is possible that a 
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person with hypertension may have multiple diseases. 
Therefore, further studies are necessary to confirm the 
significance of hypertension.
　4） Use of motivation for consultation
　Previously, many SAS patients sought consultation 
with the main complaint of daytime somnolence, but 
the results of this study clarified that CPAP users’ 
motivation for consultation has diversified, with SAS 
being indicated by medical personnel as a result of 
cardiovascular and ischemic cerebrovascular diseases.
　Furthermore, patients with subjective symptoms, 
such as daytime somnolence and headache, generally 
have better adherence32）. However, the results of this 
study revealed that many participants in the insufficient 
adherence time group had subjective symptoms. In 
other words, despite subjective symptoms and clinical 
advice, the use of CPAP has not been effective. This 
finding matches reports that daytime somnolence does 
not correlate with adherence33）. Further, even if the 
daily usage time is short in the insufficient adherence 
time group, this practice has become a habit, so it 
is considered difficult to shift these people to the 
good adherence group. Therefore, if patients in the 
insufficient adherence time group also have subjective 
symptoms, then it is easier to motivate these patients, 
and this should be the group that is easiest to instruct.
　The study also revealed that there tended to be more 
participants who sought consultation after a company 
medical checkup in the insufficient adherence days 
group, where the participants infrequently use the 
CPAP machine, despite using it for a longer period 
of time per night. Sleep management is mandated in 
company medical checkups in industries that employ 
drivers, and these people’s lifestyle background and 
sleep environment can be affected by shift work and 
difficulties securing a power source for CPAP machines. 
Thus, it is essential to provide intervention that suits 
the lifestyle of these CPAP users, including use of self-
powered CPAP machines.
　No previous studies investigated the motivation for 
consultation, but given that significant differences were 
observed in certain areas in each group, in the future, 
it may be possible to discover characteristics of CPAP 
users from motivation for consultation as a factor that 
affects adherence.
　5） Use of four grouping
　Previous guidance and management methods 
provided guidance to ensure good acceptance of 
the therapy, including providing knowledge and 
education on the necessity of CPAP, mask fitting, and 
using appropriate pressure setting, prioritizing these 
interventions in the early stage of CPAP introduction, 
and then, if problems occur, taking measures to resolve 
those problems. Emphasis was placed on seeking 
behavioral changes in users with poor adherence. 
However, just as CPAP machines have progressed 
to better suit the natural sleep of users, as medical 
personnel, we also must adapt to better suit the lifestyle 
of diversified CPAP users. When doing so, using the 
more subdivided grouping of “good adherence group”, 
“insufficient adherence time group”, “poor adherence 
group”, and “insufficient adherence days group” will 
make it easier to intervene based on determining the 
priority and importance of intervention, rather than 
simply finding the poor adherence group by simply 
grouping adherence into the two conventional groups, 
“good adherence group” and “poor adherence group”. 
Ascertaining the characteristics of each group will lead 
to personalized care.
　３．Limitations and issues with this study
　Since this study was carried out at a single center, 
regional effects may have been overlooked. Therefore, 
it is necessary to expand the study population to 
include the whole country.
　Moreover, since BMI was analyzed before CPAP 
introduction but not after CPAP introduction, the basis 
for weight management guidance may be insufficient.
　Since the information was obtained from medical 
records and there was no unified category for medical 
history and motive for medical examinations, it is 
possible that there may be bias due to differences in 
the individual abilities of doctors and nurses.
　Conclusion
　In this study, we found that CPAP users can be 
grouped into four groups, with differences in age, 
usage history, BMI, medical history, and motivation for 
consultation among these groups. This suggests that 
each group has different characteristics. This finding 
is considered useful for formulation of policies and 
construction of an educational system during clinical 
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practice for intervention, prioritizing consideration of 
the individuality of CPAP users when implementing 
guidance and management to maintain good adherence.
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［方法］2016 年 10 月〜 11 月に CPAP 外来を受診した患者 535 人を対象とし，CPAP 使
用状況や身体データ等のデータを収集した。「使用率」を縦軸，「使用日の平均使用時間」
を横軸とし，散布図を作成した。「70%」と「 4 時間」の値で 2 軸を交差させ，対象者
を 4 群化し，右上を良好群「≧ 70%/ ≧ 4 時間」とし，反時計回りに，時間不足群「≧
70%/ < 4 時間」，不良群「<70%/< 4 時間」，日数不足群「<70%/ ≧ 4 時間」とした。χ2
検定，Kruskal-Wallis 検定を使用し，アドヒアランスの影響要因について 4 群比較を行った。
［結果］良好群（n = 393）が全体の 7 割を占め，従来は不良群として一括りにされていた
残りの 3 割は，時間不足群（n = 31），不良群（n = 49），日数不足群（n = 62）に分配さ
れた。性別や残存 AHI に有意差は認めず，年齢や使用歴，BMI は，良好群と不良群に有
意差を認め，高血圧の割合は，良好群と日数不足群に有意差を認めた。日数不足群と時間
不足群では，自覚症状の有無の割合，良好群と時間不足群では，企業健診で指摘された割
合に有意差を認めた。
［結論］「使用率」と「使用日の平均使用時間」からアドヒアランスの 4 群化は可能であり，
個別性を重視する指導管理システム構築の一助になりうることが示唆された。
